Other health systems, including Beaumont Health, Michigan Medicine and Detroit Medical Center, said they were unlikely to mandate a vaccine before full U.S. Food and Drug Administration approval of the vaccines. As of now, all of the COVID-19 vaccines are approved under Emergency Use Authorization. Pfizer and Moderna have applied for full approval from the FDA and a decision on both is expected in the fall. Johnson & Johnson has not yet.
Vaccinations are credited with the sharp decline in COVID-19 hospitalizations and cases across the state. Between June 25-28, the state confirmed just 20 cases and 318 patients hospitalized with a confirmed or probable case — the lowest totals since the first surge in April 2020.
There are 22 patients hospitalized with COVID-19 across Henry Ford's six hospitals.
Concerns over the delta variant of the coronavirus is becoming more prevalent across the U.S. and Michigan.
As of June 24, the variant, which is the most deadly and contagious version of the virus to date, has been identified in eight Michigan counties with 32 cases. Across the U.S., it's become the dominant variant, representing more than 20 percent of all new COVID-19 cases.
Still, the vaccines are proving effective at preventing illness from the variant. Research suggests two doses of the Pfizer or Moderna vaccines are about 88 percent effective against the variant. Johnson & Johnson's vaccine effectiveness is estimated at 60 percent.
The variant leaves "hospitals vulnerable to potential future surges," Henry Ford Health System said in a news release.
"We have consistently advocated for vaccination as the best path forward for all of us," Riney said in the news release. "But for vaccinations to truly make a deep and lasting impact on this pandemic, we need everyone in this fight. There is no greater compassion we can show each other than to be vigilant about safety and preventing the spread of this devastating disease."
Source link
[ad_2]
source https://earn8online.com/index.php/299186/henry-ford-health-system-to-require-covid-19-vaccine-for-all-employees/
No comments:
Post a Comment